The Extraordinary General Meeting (EGM) of 4basebio AG took place on 3rd November 2020 at 12 pm (noon) CET as an online meeting. To see a recording of the webcast of the EGM follow this link.
Documents for the Extraordinary General Meeting (most of documents only available in German):
Presentation for the EGM (in German)
Results of the EGM (Summary in German)
Convening:
Draft spin-off agreement and spin-off reports:
- Draft Spin-off and Acquisition Agreement of 29 September 2020 (English Convenience Translation)
- Joint demerger report (with valuation report) [Gemeinsamer Spaltungsbericht (mit Bewertungsgutachten) in German]
- Spin-off audit repor [Abspaltungsprüfungsbericht - in German]
Annual financial statements and management reports for the last three financial years:
- Annual Report 2019 (english)
- Jahresabschluss 2019 (Einzelabschluss)
- Annual Report 2018 (english)
- Jahresabschluss 2018 (Einzelsbschluss)
- Annual Report 2017 (English)
- Jahresabschluss 2017 Einzelabschluss)
- Jahresabschluss der 4basebio SE zum 31. Dezember 2019 (in German)
Interim balance sheets:
- Interim financial statements of 4basebio AG as of 30 June 2020 (in German)
- Interim financial statements of 4basebio SE as of 31 August 2020 (in German)
Reports on the spin-off capital increase at 4basebio SE:
- Report on the capital increase in kind and post-formation audit for 4basebio SE (in German)
- Post-formation report of 4basebio SE (in German)
Reports on the transfer of the registered office of 4basebio SE:
Other documents:
- Curriculum vitae of Joseph M. Fernandez
- Curriculum vitae of Peter Llewellyn-Davies
- Curriculum vitae of Hansjörg Plaggemars
- Curriculum vitae of Alexander Link
- Current articles of association of 4basebio AG (in German)
- GCGC Declaration of Conformity
- Information on total number of shares and voting rights (in German)
- Explanatory notes in accordance with § 121 (3) No. 3 AktG on the rights of shareholders (in German)
- Proxy voting form